EN IT

Reserved

Recursion Pharmaceuticals: il ribasso rallenta, la conferma chiude in crescita

·44 min read
EXECUTIVE VIEW

Recursion Pharmaceuticals è alla 3ª settimana di un segnale di vendita. La conferma si è chiusa in crescita e il modello suggerisce di uscire dalla posizione: segnale indebolito, operatività sconsigliata.

Reserved analysis Subscribe to read →
Reserved

Recursion Pharmaceuticals: the decline stalls, confirmation week closes bullish

·43 min read
EXECUTIVE VIEW

Recursion Pharmaceuticals is in its 3rd week of a sell signal. The confirmation week closed bullish and the model suggests exiting the position: weakened signal, trading not recommended.

Reserved analysis Subscribe to read →
Reserved

Recursion Pharmaceuticals: il segnale di vendita regge ma la conferma frena

·43 min read
EXECUTIVE VIEW

Segnale di vendita alla 2ª settimana su Recursion Pharmaceuticals, ma la settimana di conferma si è chiusa in crescita. IQS a 56, struttura ribassista intermedia, banda di qualità sconsigliata: la disciplina suggerisce di uscire dalla posizione.

Reserved analysis Subscribe to read →
Reserved

Recursion Pharmaceuticals: sell signal holds but confirmation week pushes back

·42 min read
EXECUTIVE VIEW

Sell signal in week 2 for Recursion Pharmaceuticals, but the confirmation week closed bullish. IQS at 56, intermediate bearish structure, trading not recommended: discipline points to exiting the position.

Reserved analysis Subscribe to read →
Reserved

Recursion Pharmaceuticals: segnale fresco in un quadro ad alto rischio

·42 min read
EXECUTIVE VIEW

Recursion Pharmaceuticals riceve un segnale settimanale di vendita alla 1ª settimana. Forza del segnale bassa a 22 su 100, operatività sconsigliata secondo il nostro modello: setup ad alto rischio.

Reserved analysis Subscribe to read →
Reserved

Recursion Pharmaceuticals: fresh sell signal in a high-risk setup

·42 min read
EXECUTIVE VIEW

Recursion Pharmaceuticals gets a fresh weekly sell signal in week 1. Signal strength is low at 22 out of 100, and our model flags elevated-risk conditions: trading not recommended.

Reserved analysis Subscribe to read →
Share WhatsApp Telegram Gmail LinkedIn